摘要:
A liner holds objects in place within a form for a poured wall. The liner includes a backing sheet and a plurality of foam bed joints arranged in a substantially parallel fashion along a length dimension. A plurality of separate foam head joints are attached along a height dimension, wherein opposing ends of the foam head joints engage adjacent bed joints to define a plurality of regions on the backing sheet for receiving the objects to be cast in the poured wall. Each foam joint has a rounded cross section to form a curved grout line between the objects cast in the poured wall. The foam joints include an outer protective skin to prevent the poured wall material from bonding with the foam cells. A method of forming the liner includes aligning the separate foam bed joints and head joints in a grid and then pressing an adhesive-backed paper sheet against the foam joints.
摘要:
Various safety systems for power tools, and in particular table saws include detection systems for detecting a dangerous condition relative to a blade of the power tool, reaction systems for taking mitigation action in response to detection of a dangerous condition. The safety system may detect, prevent, and/or mitigate a dangerous condition associated with the power tool.
摘要:
Various safety systems for power tools, and in particular table saws, include detection systems for detecting a dangerous condition relative to a blade of the power tool, and reaction systems for taking mitigation action in response to detection of a dangerous condition. The safety system may detect, prevent, and/or mitigate a dangerous condition associated with the power tool.
摘要:
This invention relates to novel sulfone 2I3-dihydroimidazo[1 l2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis mediated disorders, as a sole agent or in combination with other active ingredients.
摘要:
A self-contained, controlled access, triathlon complex is described that includes a dedicated artificial body of water having a swimming starting point and a swimming finish point; dedicated biking roadway having a biking starting point adjacent the swimming finish point, and a biking finish point; a dedicated running path having a running starting point adjacent the biking finish point, and a running finish point; and an access limiting boundary surrounding the body of water, biking roadway and running path, the boundary including at least one gate for allowing controlled access to the complex.
摘要:
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
摘要:
Provided in embodiments of the present invention is a gaming device with a player interaction mechanism included in a gaming machine handle. In one embodiment, a gaming device operable by a player includes a gaming cabinet housing a processor to operate gaming sessions on the gaming device and having a display to visually represent the outcome of the gaming session. The gaming device also includes a first player interaction mechanism arranged on the gaming cabinet, a gaming handle attached to the gaming cabinet, and a second player interaction mechanism located on the gaming handle.
摘要:
This invention relates to urea compounds containing a pyridine, quinoline, or isoquinoline functionality which is oxidized at the nitrogen heteroatom and which are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angogenesis disorders.
摘要:
Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.